News > Novak Djokovic holds major stake in firm developing Covid drug

Novak Djokovic holds major stake in firm developing Covid drug

Firstpost | 20/01/2022 12:07 PM | Click to read full article

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment, the Danish company's CEO said Wednesday.

"He is one of the founders of my company we founded in June 2020," the chief executive of QuantBioRes, Ivan Loncarevic, told AFP.